What is MOTS-c?
MOTS-c is a peptide encoded within mitochondrial DNA. It is an active area of metabolic research, studied for roles in energy regulation and exercise response.
It is not FDA-approved and is among the peptides under the 2026 compounding review. Research is early-stage.
How it is thought to work
MOTS-c is studied for its role in mitochondrial function and metabolic regulation, including how cells respond to exercise and energy stress.
What the research shows
Most MOTS-c research is preclinical or early-stage. Human outcome data is limited, so expectations should be modest.
We summarize published research and do not make therapeutic promises. A licensed provider can evaluate whether any therapy is appropriate for you. Treat any source promising guaranteed results with skepticism.
Studied uses
- Metabolic and energy research
- Exercise-response studies
- Healthy-aging interest
Legal status in 2026
MOTS-c is not FDA-approved and is among the peptides under federal review in 2026. No rule has changed yet, and it would remain prescription-only even if reclassified.
How to access MOTS-c legitimately
A licensed provider can review whether it is suitable for you and, where permitted, prescribe through a licensed compounding pharmacy.
PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.
Frequently asked questions
What is MOTS-c? A peptide derived from mitochondrial DNA, studied for metabolic regulation. It is an early-stage research compound.
Is it legal now? It is not approved. Where permitted it requires a prescription, and its compounding status is under 2026 review.
Does PeptideForward sell it? No. We connect you with licensed providers only.